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Hepatitis E virus (HEV) strains are classified into 4 genotypes by nucleo-
tide sequencing. Genotypes 3 and 4 infect humans and animals via HEV-
contaminated food or water. HEV RNA was detected by PCR and antibodies were 
detected by ELISA. Since human studies showed that HEV IgG antibodies in sera 
can persist for extended periods, diagnosis of HEV infection in swine or humans 
is mainly based on serological detection using commercial ELISA kits. However, 
there is no supplemental method to verify ELISA results. Hence, we developed a 
novel method used for mutual correction of these common processes. Here, a 
modified stable HepG2 cell line was transfected with pcDNA3.1-ORF3 to express 
the swine HEV ORF3 protein. Based on this cell line, a novel immunoperoxidase 
monolayer assay (IPMA) was developed to detect antibodies against HEV. The 
results show that this method has good specificity, sensitivity and repeatability. 
When used to investigate 141 porcine serum samples, the IPMA had a coinci-
dence rate of 92.2% with a commercial ELISA kit. The established IPMA de-
scribed herein is valuable as a supplemental method to ELISA and can differenti-
ate infections by HEV and other viruses. 
Key words: Hepatitis E virus (HEV), immunoperoxidase monolayer assay 
(IPMA), stable expressing cell line, ORF3  
Hepatitis E virus (HEV) is an important zoonotic agent worldwide and 
leads to severe hepatitis E outbreaks in Asia and Africa (Cooper et al., 2005). In 
the developing countries, hepatitis E mostly occurs as a waterborne disease asso-
ciated with contaminated water and poor sanitation conditions. However, acute 
hepatitis E also spreads sporadically in the industrialised countries (Purcell and 
Emerson, 2008). 
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Phylogenetic tree analysis has shown that HEV has four genotypes that 
present different pathogenicities. Genotype 1 spreads throughout Africa and 
Asia, whereas genotype 2 is epidemic in Mexico, Nigeria and Chad. Both are 
prevalent in hyperendemic regions and cause severe liver disease in humans, but 
they cannot cross the species barrier. On the contrary, although genotypes 3 and 
4 cause mild hepatitis, they are regarded as zoonotic pathogens of swine and 
other mammals, which can be transmitted to humans and cause autochthonous 
acute HEV infections. Genotype 3 is prevalent throughout the USA, South 
America, Europe, Australasia and Japan, while genotype 4 mainly circulates in 
China, Japan, and Vietnam (Lu et al., 2006; Sarangi and Srivastava, 2011). 
The HEV genome is a linear, single-stranded, positive sense RNA of 7.2 kb 
that contains three open reading frames (ORFs) (Reyes et al., 1990; Tam et al., 
1991). ORF1 encodes a non-structural polyprotein essential for viral replication. 
ORF2 encodes a 660-amino-acid (aa) viral capsid protein that includes immu-
nodominant epitopes used for diagnosis (Zhang et al., 2008; Osterman et al., 
2012). ORF3 encodes a very small cytoskeleton phosphoprotein with putative 
regulatory functions (Chandra et al., 2008) and is essential for viral release from 
infected cells (Yamada et al., 2009). Previous studies strongly suggested that 
some ORF3 peptides were specific and highly sensitive to swine HEV (swHEV) 
and could be used as diagnostic targets to detect specific antibodies against HEV 
in serum samples (Zhao et al., 2009). 
Since HEV infection of swine is always asymptomatic, serodiagnosis or 
detection of HEV RNA is mainly used in laboratories to investigate the preva-
lence of HEV infection in swine (Jimenez de Oya et al., 2009; Peralta et al., 
2009). Recently, specific primers have been designed and sensitive reverse tran-
scription-polymerase chain reaction (RT-PCR) and nested RT-PCR have been 
developed in independent laboratories to detect HEV (Ward et al., 2009). Fur-
thermore, commercial enzyme-linked immunosorbent assay (ELISA) kits are 
widely used to detect anti-HEV immunoglobulin G (IgG) or IgM antibodies 
(Meng et al., 2002). Because of the shortage of appropriate supplemental meth-
ods, these commonly used test methods have not been validated. Thus, new 
methods are needed for mutual correction of these common tests. The immuno-
peroxidase monolayer assay (IPMA) has been developed to detect antibodies 
against some other swine viruses, such as porcine reproductive and respiratory 
syndrome virus (PRRSV) and swine influenza A virus (SIV) (Houben et al., 
1995; Direksin et al., 2002). However, an IPMA for swine HEV does not exist, 
as transient viral transfection methods into mammalian cell lines are needed to 
develop an IPMA (Direksin et al., 2002; Hornyák et al., 2004). In this study, we 
modified a traditional method to establish a stable expression cell line to express 
swHEV ORF3 proteins in order to obtain a useful IPMA for screening antibodies 
against HEV in sera. 
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Materials and methods 
Bacteria, viruses and cells 
HepG2 cells, E. coli DH5α clonal strains, an HEV SS19 (GenBank acces-
sion number: JX855794) isolate of genotype 4, and reference sera against 
PRRSV, foot and mouth disease virus (FMDV), classical swine fever virus 
(CSFV), porcine circovirus type 2 (PCV2), porcine pseudorabies virus (PRV), 
porcine parvovirus (PPV), Japanese encephalitis virus (JEV) and H3 subtype 
SIV were all provided by MOA Key Laboratory of Animal Vaccine Develop-
ment (College of Veterinary Medicine, South China Agricultural University, 
Guangzhou, China). HepG2 cells were grown in Dulbecco’s modified Eagle’s 
medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 2 mM L-
glutamine, 100 U of penicillin mL−1 and 100 μg of streptomycin mL−1. 
ORF3 amplification and recombinant plasmid construction 
For amplification of the ORF3 gene of the HEV SS19 isolate, sense (5’-
CCCAAGCTTATGGAGATGCCACCATGCG-3’) and antisense primers (5’-
CCGGATATCTACGGCGAAGCCCCAGC-3’) were designed based on the se-
quence of the HEV SS19 isolate. The underlined parts of the primer sequences 
represent restriction enzyme sites HindIII and EcoRV, respectively. The total vi-
ral RNA was extracted using Trizol (Invitrogen, Carlsbad, CA, USA) according 
to the manufacturer’s instructions. Reverse transcription was performed at 42 °C 
for 60 min using 9.5 μL of total RNA combined with 0.5 μL of RNase inhibitor 
(20 U/Μl), 4.0 μL of 5× avian myeloblastosis virus reverse transcriptase (AMV-
RT) buffer, 4.0 μL of dNTPs (2.5 mmol each), 1.0 of AMV, and 1.0 μL of re-
verse transcription primers (R:O). The amplification was performed in a 100-μL 
reaction mixture containing 2.0 μL MgSO4 (50 mM), 10.0 μL of 10× Pfx buffer, 
8.0 μL of dNTPs (2.5 mmol each), 1.5 μL of each primer, 75.0 μL ddH2O, 0.5 μL 
of Pfx DNA polymerase (2.5 U/μL) and 5.0 μL of cDNA. The PCR parameters 
included 95 °C for 4 min, 30 cycles at 94 °C for 1 min, 58 °C for 30 s, 68 °C for 
45 s, and a final extension of 10 min at 72 °C. The enzyme-digested PCR prod-
ucts were cloned into the HindIII:EcoRV site of vector pcDNA3.1(+)/myc-His A 
(Invitrogen, Carlsbad, CA, USA). The recombinant plasmid was named 
pcDNA3.1-ORF3. 
Transfection of HepG2 cells and screening for stable expression in cell lines 
The G418 culture medium was diluted from 1000 to 100 μg/mL in 100 μg/mL 
increments to construct the selective medium. A HepG2 cell suspension was pre-
pared and inoculated into a 96-well culture plate. After 6 h of incubation, the cul-
ture medium was discarded and the cells were washed with sterile phosphate-
buffered saline (PBS) of pH 7.2, then different concentrations of screening cul-
246 LIANG et al. 
Acta Veterinaria Hungarica 62, 2014 
ture medium were added into each well with 3 groups of parallel repeats of each 
concentration. Depending on the colour of the medium and the cell growth con-
ditions, the culture medium was changed every 3–5 days over 10–14 days and 
the one which killed all cells with a minimal G418 concentration was the optimal 
screening concentration. 
HepG2 cells were inoculated into 12-well plates (1 × 105/well) the day be-
fore transfection. Prior to transfection, cells were washed twice with OptiMEM 
(Gibco-Life Technologies, Grand Island, NY, USA). Serum-free Opti-MEM I 
Medium (Invitrogen) and pcDNA3.1-ORF3 were mixed in a tube. Then, Lipofec-
tamine 2000 (Invitrogen) was mixed with the serum-free Opti-MEM I Medium. 
After 5 min, the transfection mixture was mixed with the OptiMEM-liposome mix-
ture, which was added to the cell culture medium. After 20 min, the culture was in-
cubated at 34.5 °C in a humidified atmosphere of 5% CO2 for 4–6 h. Then, the 
mixture was aspirated and fresh medium was added and incubated at 34.5 °C for 
24–48 h. Passaged cells were planted into fresh growth medium with G418 at an 
optimal concentration until the cells reached 50–70% confluence. Based on me-
dium colour and cell growth, G418 should be added to maintain screening. After 
selection for 10–14 days, G418-resistant clones were selected using an expand-
ing culture. Cells were diluted with culture medium to 1/10 μL and inoculated in 
48-well plates for proliferation and the stably expressed ORF3-transfected cells 
were selected. The modified cell line was named HepG2-ORF3. 
Detection of eukaryotic expression via RT-PCR  
and an immunofluorescence assay (IFA) 
In order to detect the ORF3 mRNA expression in HepG2-ORF3 cells by 
RT-PCR, total RNA was extracted from HepG2 cells. Single-stranded cDNA 
was synthesised from total RNA using AMV-RT (TaKaRa, Tokyo, Japan). PCR 
was carried out using the primers for ORF3 to produce a 345-bp product. 
The IFA was used to detect the expression of specific ORF3 HEV proteins 
in HepG2 cells. Briefly, cells were fixed for 20 min with methanol at –20 °C. Af-
ter washing with PBS, cells were incubated with anti-His antibody (Sigma, USA) 
at 37 °C for 1 h, washed with PBS three times, and then incubated with anti-
mouse IgG/DyLight488 for 1 h at 37 °C in the dark. After washing, the percent-
age of positive cells was evaluated via fluorescence microscopy. 
Growth curves of HepG2-ORF3 transfected cells 
To determine the optimal growth conditions of pcDNA3.1-ORF3 in 
HepG2 cells, the 3-(4,5 dimethylthiozol-2-yl)-2,5-diphenyl-tetrazolium bromide 
(MTT) assay was used. An experimental group with HepG2-ORF3-transfected 
cells and a control group with non-transfected cells were established. The above 
cells were inoculated in 96-well plates and the total cell number was quantified 
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daily using the MTT assay. Next, 20 μL of MTT (5 mg/mL) was added to each 
well and incubated at 37 °C for 4 h. After discarding the supernatant, 100 μL of 
dimethyl sulphoxide was added to each well. The cellular growth conditions 
were monitored using a microplate reader with a 490-nm filter and expressed as 
optical density (OD). 
Development of an IPMA for HEV diagnosis 
Before performing the IPMA assay, suspensions of HepG2-ORF3 and 
HepG2 cells were fixed in 96-well plates, with HepG2-ORF3 cells in columns 1, 
3, 5, 7, 9 and 11 and HepG2 cells in columns 2, 4, 6, 8, 10 and 12. Cells were incu-
bated at 37 °C in a humidified atmosphere of 5% CO2 and then acetone at –20 °C 
was added to fix the cells in monolayers. 
Matrix analysis was applied to determine the optimal reaction conditions 
of the IPMA. The positive and negative serum samples from swine identified by 
a commercial ELISA kit were diluted using a double dilution method with a 
starting dilution of 1:25. Horseradish peroxidase-labelled protein A of Staphylo-
coccus aureus (HRP-SpA) as the reference antiserum was diluted to 1:500, 
1:1000, 1:2000 and 1:3000 before use. The stably expressed HepG2-ORF3 cells 
were fixed for 10 min at 4 °C using cold 4% paraformaldehyde in PBS and 
washed three times with PBS. Serum samples were diluted in PBS + 0.1% 
Tween-20 (PBST) with 0.5% gelatine and then added to the wells, incubated at 
37 °C for 1 h, and washed three times with PBST. Different concentrations of 
HRP-SpA were added to each well (100 μL/well) and incubated for 1 h at 37 °C. 
After washing three times with PBST, 3-amino-9-ethyl-carbazole (AEC) sub-
strate was prepared according to the manufacturer’s instructions, added to the 
wells, and incubated at 37 °C for 15 min. After another washing, the cells were 
dried and then examined under an inverted microscope. Wells with HepG2-
ORF3 cells incubated with negative sera and wells with only HepG2 cells remain 
unstained, whereas wells containing HepG2-ORF3 cells and incubated with posi-
tive sera were stained reddish-brown. 
Characteristic analysis of the IPMA assay 
To test the specificity of the IPMA, reference sera against PRRSV, 
FMDV, CSFV, PCV2, PRV, PPV, JEV and H3 subtype SIV were examined to 
determine cross-reactions of the HepG2-ORF3 cell line. Positive sera of anti-
swHEV antibody were diluted using a double dilution method with a starting 
concentration of 1:25 to determine the sensitivity of the IPMA. 
To determine the repeatability of this method, sera obtained from the same 
or different batches were tested. In total, 141 random swine serum samples were 
examined via IPMA and ELISA (Wantai Biological Pharmacy Co., Beijing, 
China) to compare the positive rates and calculate the total coincidence rate. 
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Results 
Amplification of ORF3 and construction of pcDNA3.1-ORF3 
The fragment from HEV ORF3 was PCR-amplified with primers contain-
ing HindIII and EcoRV sites. PCR products were analysed by agarose gel elec-
trophoresis and the results indicated that a 345-bp fragment of ORF3 was suc-
cessfully obtained. The enzyme-digested PCR products were inserted into the 
expression vector pcDNA3.1(+)/myc-His A. The correctness of the insert was 
confirmed by agarose gel electrophoresis and DNA sequencing (Fig. 1A). 
Eukaryotic expression and growth curve assays of HepG2-ORF3 
To confirm the expression of ORF3 mRNA in HepG2 cells, total RNA 
was extracted from G418-resistant monoclonal cells. Three rRNA bands (28S, 
18S and 5S) could be clearly seen in the agarose gels (Fig. 1B). RT-PCR results 
showed that the predicted 345 bp fragment was obtained (Fig. 1C). 
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Fig. 1. Results of agarose gel electrophoresis detection. (A) The recombinant plasmid pCDNA3.1-
ORF3 was digested with HindIII:EcoRV. Agarose gel electrophoresis results showed that  
fragments > 345 bp were obtained in lanes 1 and 2. Lane M1, DNA 15,000 marker; lanes 1–2, 
pCDNA3.1-ORF3 double enzyme digest; lane 3, pCDNA3.1-ORF3 enzyme digest; lane M2, DNA 
100 marker. (B). Total RNA was obtained from G418-resistant monoclonal cells and digested by 
DNase I (RNase free). Lane M, DNA 2000 marker; lanes 1–2, 3 rRNA bands extracted from 
monoclonal cells visualised via agarose gel electrophoresis; lane 3, blank control. (C) RT-PCR  
detection of HepG2-ORF3 cells to confirm the expression of HEV ORF3. Results showed that the 
predicted fragments of 345 bp were obtained as expected. Lane M, DNA 2000 marker; lanes 1–2, 
RT-PCR detection of cells transfected with pCDNA3.1-ORF3 cell; lane 3, RT-PCR detection of 
cells transfected with pCDNA3.1-ORF3 cell treated with DNase for contrast 
 
An IFA was performed to confirm ORF3 expression in HepG2 cells. Re-
sults demonstrated that the HEV ORF3 protein was expressed in HepG2 cells. 
On the contrary, no fluorescence was detected in the negative control cells (Fig. 2). 
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There were no obvious differences in growth conditions between the experimen-
tal and control groups. Furthermore, there were no cytopathic effects on the 
HepG2 cells (data not shown). 
 
 
Fig. 2. Expression of swHEV ORF3 in HepG2 cells via IFA (×20). (A) Green fluorescence is seen 
in HepG2 cells transfected with recombinant plasmid pCDNA3.1-ORF3. (B) Negative control cells 
transfected with pcDNA3.1(+)/myc-His A 
 
The MTT assay was used to investigate the effects of the recombinant 
plasmid pcDNA3.1-ORF3 on HepG2 cell proliferation. Our results indicated that 
HepG2-ORF3-transfected cells maintained exponential growth for 1–3 days and 
then reached a plateau (data not shown). 
Characteristics analysis of IPMA for HEV using the HepG2-ORF3 cell line 
Matrix analysis was used to determine the optimal reaction conditions. 
Our results showed that the dilution of HRP-SpA should be 1:3000 and the opti-
mum concentration of sera was 1:100. Inverted microscopy showed that wells 
containing HepG2-ORF3 cells and incubated with positive sera were stained a 
reddish-brown colour (Figs 3A and 3C). However, wells with HepG2-ORF3 
cells incubated with negative sera and those containing only HepG2 cells re-
mained unstained (Figs 3B and 5D). 
To evaluate the specificity of this method, reference sera against PRRSV, 
FMDV, CSFV, PCV2, PRV, PPV, JEV and H3 subtype SIV were examined via 
IPMA using the HepG2-ORF3 cell line. No serological cross-reactions were pre-
sent and the specificity was confirmed (Fig. 4). 
Results of the sensitivity test revealed that even if incubated with a serum 
sample at a dilution lower than 1:200, specific cell staining could be clearly seen 
(Fig. 5). 
A B
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Fig. 3. Colour changes of IPMA between the experimental and control groups. HepG2-ORF3 cells 
were passaged after transfection and cultured in 96-well plates for detection using positive swHEV 
sera as the primary antibody. (A) HepG2-ORF3 cells incubated with swHEV positive sera (×20); 
(B) HepG2 cells incubated with swHEV positive sera (×20); (C) HepG2-ORF3 cells incubated 
with swHEV positive sera (×40); and (D) HepG2 cells incubated with swHEV positive sera (×40). 
A reddish-brown colour could be seen in the experimental group 
 
To test the repeatability of the IPMA assay, three plates were assembled 
from the same batch and three from different batches. All of the results were 
consistent and revealed that there were no differences between the same or dif-
ferent batches (data not shown). 
Comparison tests between the ELISA and IPMA using the HepG2-ORF3 cell line 
The positivity rate of the IPMA using the modified cell line was compared 
with the ELISA results. A total of 141 random swine serum samples were exam-
ined by both methods (Table 1). The results showed that there were 127 positive 
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and 14 negative serum samples detected by the IPMA, whereas the ELISA de-
tected 124 positive and 17 negative serum samples. Hence, the IPMA was more 
specific and much more sensitive than the ELISA. Meanwhile, the total coinci-
dence rate between the methods was 92.2%, suggesting that the IPMA developed 
in this study can be used as an alternative test for swine HEV. 
 
 
Discussion 
Major antigenic epitopes of HEV contained in ORF2 and ORF3 
(Yarbough et al., 1991; Khudyakov Yu et al., 1994) could be used as the ideal 
diagnostic targets for HEV detection (Dawson et al., 1992). ORF2 is located at 
the 3’ end of the genome and encodes a capsid protein that encapsulates the viral 
RNA genome and contains an endoplasmic reticulum (ER) signal peptide and 3 
putative N-glycosylation sites (Graff et al., 2008), which have been the focus of 
studies of antigenic sites (Ma et al., 2009; Pan et al., 2010). However, recent 
studies compared the polypeptide ends of the ORF1, ORF2 and ORF3 proteins. 
The results demonstrated that the ORF3 protein had high specificity and sensitiv-
ity to detect anti-HEV IgG and IgM antibodies and was expected to be a poten-
tial diagnostic target (Kai et al., 2009). The ORF3 peptides should provide effi-
cient development of an accurate and rapid swHEV detection method. The ORF3 
fragment of swHEV strain SS19 was used as an antigen to establish an IPMA to 
detect specific swHEV antibodies in this study. Customarily, an IPMA is used to 
monitor antigen by inoculating viruses into cells (Khudyakov Yu et al., 1994; Di-
reksin et al., 2002; Guedes et al., 2002), which involves complicated procedures 
and unstable antigen content. A recent study suggested that cells stably express-
ing the major viral antigen could be used for IPMA (Sagong et al., 2010). In the 
present study, we developed an IPMA for the detection of swHEV antibodies us-
ing modified HepG2 cell lines that stably expressed the ORF3 protein as a diag-
nostic target. 
Current ELISA kits for the detection of antibodies were compared with 
IPMAs in many studies and the results were diverse. Soliman et al. (1997) and 
Houben et al. (1995) found that the IPMA was less sensitive than the ELISA. In 
contrast, Yoon et al. (1995) reported that the IPMA performed slightly better 
than a commercial ELISA kit to monitor the appearance and longevity of anti-
body responses in experimentally infected animals. However, the IPMA based 
on stable expression in cell lines established in the present study was convenient 
and repeatable. The specificity of this method was confirmed by antibody reac-
tions against other viruses. Furthermore, a total of 141 swine serum samples 
were simultaneously subjected to IPMA and ELISA and the results indicated that 
the total coincidence rate between the two methods was 92.2%. 
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Fig. 4. Specificity testing of the IPMA. Pictures A–I are the results of HepG2-ORF3 cells reacted 
with the reference serum against HEV, RRSV, FMDV, CSFV, PCV2, PRV, PPV, JEV and H3 
subtype SIV, respectively. Picture J was the blank result of HepG2-ORF3 cells inoculated with 
PBS. Results showed that a reddish-brown colour was only seen in Picture A 
Above all, we developed a stable HepG2 cell line constitutively express-
ing the specific swHEV ORF3 protein. The modified cell line showed good reac-
tivity with specific antibodies against swHEV. Thus, the IPMA based on this cell 
line offers an alternative method to detect swHEV. Further, the colour indicating 
a positive reaction in the IPMA was stable for several months; therefore, it can 
provide a lasting record of test results. Although this method seemed to be 
somewhat subjective, it was convenient and simple. In contrast with the ELISA, 
the present IPMA did not require highly purified antigens and was relatively lower 
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in cost compared with the expensive commercial ELISA kit. Furthermore, when 
performing serological and epidemiological surveys, the IPMA presents a bene-
ficial supplement to an ELISA. 
Table 1 
Compliance test between IPMA and ELISA 
ELISA 
Methods 
+ – 
Total no. detected  
by IPMA 
+ 120 7 127 IPMA – 4 10 14 
Total no. detected by ELISA 124 17 141 
Total coincidence rate, % 92.2 
+: positive no., –: negative no. 
 
In conclusion, the established IPMA described in this paper is valuable for 
detecting and differentiating HEV infections from other commonly occurring vi-
ruses. Meanwhile, the present methodology has the potential to develop a stable 
expressing cell-line-based novel detection technique for other pathogens. 
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